SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

A pragmatic pipeline for drug resistance and lineage identification in Mycobacterium tuberculosis using whole genome sequencing

Elton, L; Aydin, A; Stoker, N; Rofael, S; Wildner, LM; Abdul, JBPAA; Tembo, J; Hamid, MA; Claujens Chastel, MM; Canseco, JO; et al. Elton, L; Aydin, A; Stoker, N; Rofael, S; Wildner, LM; Abdul, JBPAA; Tembo, J; Hamid, MA; Claujens Chastel, MM; Canseco, JO; Doyle, R; Satta, G; O’Grady, J; Witney, A; Ntoumi, F; Zumla, A; McHugh, TD (2025) A pragmatic pipeline for drug resistance and lineage identification in Mycobacterium tuberculosis using whole genome sequencing. PLOS Global Public Health, 5 (2). e0004099. ISSN 2767-3375 https://doi.org/10.1371/journal.pgph.0004099
SGUL Authors: Witney, Adam Austin

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview
[img] Microsoft Word (.docx) (S1 Text) Supplemental Material
Available under License Creative Commons Attribution.

Download (15kB)
[img] Microsoft Word (.docx) (S1 Table) Supplemental Material
Available under License Creative Commons Attribution.

Download (15kB)
[img] Microsoft Word (.docx) (S2 Table) Supplemental Material
Available under License Creative Commons Attribution.

Download (14kB)
[img] Microsoft Word (.docx) (S3 Table) Supplemental Material
Available under License Creative Commons Attribution.

Download (19kB)
[img] Microsoft Word (.docx) (S4 Table) Supplemental Material
Available under License Creative Commons Attribution.

Download (48kB)
[img] Microsoft Word (.docx) (S5 Table) Supplemental Material
Available under License Creative Commons Attribution.

Download (42kB)
[img] Microsoft Word (.docx) (S6 Table) Supplemental Material
Available under License Creative Commons Attribution.

Download (49kB)

Abstract

Delays in accurate diagnosis of drug resistant tuberculosis (DR-TB) can hinder treatment. Whole genome sequencing (WGS) provides more information than standard molecular and phenotypic testing, but commonly used platforms are expensive to implement, and data interpretation requires significant expertise. We aimed to optimise a TB WGS diagnostic pipeline balancing user-friendliness, cost-effectiveness and time to results, whilst ensuring accuracy. Growth conditions, DNA extraction protocols and Oxford Nanopore Technologies (ONT) library preparation kits were compared. ONT was compared with Illumina protocols. Software for basecalling and analysis were evaluated to find the most accurate resistance SNP and lineage predictor. Optimally, a spin-column CTAB DNA extraction method was combined with the RBK110.96 library preparation kit, high accuracy (HAC) basecalling and data analysis using TB-Profiler. Compared with Illumina, the pipeline was concordant for 16/17 (94%) isolates (lineage) and for 17/17 (100%) isolates (resistance SNPs). Our pipeline was 71% (12/17) concordant with phenotypic drug susceptibility test (DST) results. Time-to-diagnosis was around four weeks. This optimised TB sequencing pipeline requires less time and expertise to run and analyse than Illumina, takes less time than phenotypic DSTs and the results are comparable with Illumina. The cost per sample is comparable with other methods. These features make it an important tool for incorporating into routine DR-TB diagnostic pipelines and larger scale drug resistance surveillance in all settings.

Item Type: Article
Additional Information: Copyright: © 2025 Elton et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: PLOS Global Public Health
Editors: Muñiz-Salazar, R
ISSN: 2767-3375
Language: en
Dates:
DateEvent
10 February 2025Published Online
3 December 2024Accepted
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
UNSPECIFIEDEuropean and Developing Countries Clinical Trials Partnershiphttp://dx.doi.org/10.13039/501100001713
URI: https://openaccess.sgul.ac.uk/id/eprint/117157
Publisher's version: https://doi.org/10.1371/journal.pgph.0004099

Actions (login required)

Edit Item Edit Item